Publications

2024 

• A multicellular liver organoid model for investigating hepatitis C virus infection and nonalcoholic fatty liver disease progression. Lee J, Gil D, Park H, Lee Y, Mun SJ,   Shin Y, Jo E, Windisch MP, Kim JH (교신저자), Son MJ. Hepatology (IF 17.4)   80(1):p 186-201, July 2024. doi: 10.1097/HEP.0000000000000683

• Guidelines for Manufacturing and Application of Organoids: Lung.  Lim K, Lee MO, Choi J, Kim JH, Kim EM, Woo CG, Chung C, Cho YH, Hong SH, Cho YJ, Ahn SJ. Int J Stem Cells. 2024 May 30;17(2):147-157. doi: 10.15283/ijsc24041.

• KSCBi005-A-10(hiPSC-HIF1alphaKO), a HIF1alpha knockout human induced pluripotent stem cell line, for demonstrating the role of cellular response to hypoxia. Han HJ, Kim JH (교신저자). Stem Cell Res. 2024 Jun;77:103415. doi: 10.1016/j.scr. 2024.103415 

• Epigenetic repression of CHCHD2 enhances survival from single cell dissociation through attenuated Rho A kinase activity. Kim J, Kwon EJ, Kim YJ, Kim D, Shin YZ, Gil D, Kim JH, Shin HD, Kim LH, Lee MO, Go YH, Cha HJ. Cell Mol Life Sci. 2024 Jan 12;81(1):38. doi: 10.1007/s00018-023-05060-8.

2023

• KSCBi005-A-8(hiPSC-PD-L1KO), a PD-L1 knockout human induced pluripotent stem cell line for demonstrating the role of the PD-1/PD-L1 axis., Han HJ, Kim JH (교신저자)., Stem Cell Res. 2023 Oct;72:103196. doi: 10.1016/j.scr.2023.103196. Epub 2023 Sep 1.

• Reciprocal enhancement of SARS-CoV-2 and influenza virus replication in human pluripotent stem cell-derived lung organoids. Kim MJ, Kim S, Kim H, Gil D, Han HJ, Thimmulappa RK, Choi JH, Kim JH(교신저자)., Emerg Microbes Infect. (IF 19.6) 2023 Dec;12(1):2211685.

• Invasive FoxM1 phosphorylated by PLK1 induces the polarization of tumor-associated macrophages to promote immune escape and metastasis, amplified by IFITM1. Xu R, Lee YJ, Kim CH, Min GH, Kim YB, Park JW, Kim DH, Kim JH, Yim H. J Exp Clin Cancer Res. 2023 Nov 16;42(1):302. doi: 10.1186/s13046-023-02872-1.

2022

• • Perspectives on the cost of goods for hPSC banks for manufacture of cell therapies., Kim JH(제1저자), Kawase E, Bharti K, Karnieli O, Arakawa Y, Stacey G., NPJ Regen Med. (IF 14.4) 2022 Sep 29;7(1):54.

  • Human Pluripotent Stem Cell-Derived Alveolar Organoid with Macrophages. Seo HR, Han HJ, Lee Y, Noh YW, Cho SJ, Kim JH (교신저자), Int J Mol Sci. 2022 Aug 16;23(16):9211

  • Standard operating protocol of hepatic organoid differentiation from human induced pluripotent stem cells. Kim MJ, Lee J, Mun SJ, Son MJ, Kim JH(교신저자)., Organoid 2022 May 25

  • Single-Cell RNA Sequencing of Human Pluripotent Stem Cell-Derived Macrophages for Quality Control of The Cell Therapy Product. Jo HY, Seo HH, Gil D, Park Y, Han HJ, Han HW, Thimmulappa RK, Kim SC, Kim JH(교신저자)., Front Genet. 2022 Jan 31;12:658862

      ~ 2021

• • Generation of a TLR2 knockout human induced pluripotent stem cell line using CRISPR/Cas9. Han HJ, Kim JH(교신저자)., Stem Cell Res. (IF 2.02) 2021 Oct 19;57:102578

  •  Establishment of a TLR3 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9.Han HJ, Kim JH(교신저자)., Stem Cell Res. (IF 2.02)  2021 Apr;52:102187

  •  Modeling Toxoplasma gondii infection in human cerebral organoids. Seo HH, Han HW, Lee SE, Hong SH, Cho SH, Kim SC, Koo SK, Kim JH (교신저자)., Emerg Microbes Infect. (IF 14.21) 2020 Aug 21:1-58.

  •   Functional in vivo and in vitro effects of 20q11.21 genetic aberrations on hPSC differentiation., Jo HY, Lee Y, Ahn H, Han HJ, Kwon A, Kim BY, Ha HY, Kim SC, Kim JH, Kim YO, Kim S, Koo SK, Park MH., Sci Rep. (IF 4.99) 2020 Oct 29;10(1):18582

  •  Generation of a TLR7 heterozygous knockout line (WAe009-A-18) from human embryonic stem cells using CRISPR/Cas9. Seo HH, Han HW, Kim JH (교신저자). Stem Cell Res. (IF 2.02) 2020 May;45:101735.

  • Development of genetic quality tests for good manufacturing practice-compliant induced pluripotent stem cells and their derivatives. Jo HY, Han HW, Jung I, Ju JH, Park SJ, Moon S, Geum D, Kim H, Park HJ, Kim S, Stacey GN, Koo SK, Park MH, Kim JH (교신저자). Sci Rep. (IF 4.99) 2020 Mar 3;10(1):3939

  •   BMP4 and perivascular cells promote hematopoietic differentiation of human pluripotent stem cells in a differentiation stage-specific manner. Jeong S, An B, Kim JH, Han HW, Kim JH, Heo HR, Ha KS, Han ET, Park WS, Hong SH. Exp Mol Med. (IF 12.17) 2020 Jan;52(1):56-65.

  • Drug discovery platform targeting M. tuberculosis with human embryonic stem cell-derived macrophages, Han HH, Seo HH, Jo HY, Han H, Falcão V, Delorme V, Heo J, Shum D, Choi JH, Lee JM, Lee SH, Heo HR, Hong SH, Park MH, Thimmulappa RK, Kim JH (교신저자). Stem Cell Reports. (IF 6.87, Cell & Tissue Engineering 상위 10%) 2019, Sept Accepted

  • Generation of a KSCBi005-A-5(TLR8KO-A10) homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9. Han HJ, Han HW, Seo HH, Kim JH (교신저자). Stem Cell Res. (IF 4.49) 2019 Aug 27

  • Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9. Han HJ, Seo HH, Han HW, Kim JH (교신저자). Stem Cell Res. (IF 4.49) 2019 Jul 31;40

  • Report from a workshop of the International Stem Cell Banking Initiative, held in collaboration GAiT and the Harvard Stem Cell Institute, Boston 2017. Kim JH (제1저자), Alex A, Nissim B, Catharina B, Meri F, Harrison PW, Stacey GN. Stem Cells. (IF 6.02, Biotech & Applied microbiol 상위10%) 2019. April 25

  • Dysregulated invertebrate tropomyosin-dectin-1 interaction confers susceptibility to allergic diseases. Gour N, Lajoie S, Smole U, White M, Hu D, Goddard P, Huntsman S, Eng C, Mak A, Oh S, Kim JH, Sharma A, Plante S, Salem IH, Resch Y, Xiao X, Yao N, Singh A, Vrtala S, Chakir J, Burchard EG, Lane AP, Wills-Karp M. Science Immunology. (IF 13.44) 2018 Feb 23

  • A Standard Nomenclature for Referencing and Authentication of Pluripotent Stem Cells. Kurtz A, Seltmann S, Bairoch A, Bittner MS, Bruce K, Capes-Davis A, Clarke L, Crook JM, Daheron L, Dewender J, Faulconbridge A, Fujibuchi W, Gutteridge A, Hei DJ, Kim YO, Kim JH, Kokocinski AK, Lekschas F, Lomax GP, Loring JF.  Stem Cell Reports. (IF 6.03) 2018 Jan

  • Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells. Kim JH (제1저자), Kurtz A, Yuan BZ, Zeng F, Lomax G, Loring JF, Crook J, Ju JH, Clarke L, Inamdar MS, Pera M, Firpo MT, Sheldon M, Rahman N, O'Shea O, Pranke P, Zhou Q, Isasi R, Rungsiwiwut R, Kawamata S, Oh S, Ludwig T, Masui T, Novak TJ, Takahashi T, Fujibuchi W, Koo SK, Stacey GN.  Stem Cells Transl Med. (IF 6.43, Cell & Tissue Engineering 상위 10%) 2017 Nov

  • Generation of human induced pluripotent stem cell lines from human dermal fibroblasts using a modified RNA system, Uhm KO, Go GY, Kim SJ, Jo EH, Choi HY, Im YS, Ha HY, Kim JH, Koo SK. Stem Cell Res. (IF 4.42) 2017 Oct;24:148-150.

  • Generation of human induced pluripotent stem cell lines from human dermal fibroblasts using a non-integration system. Uhm KO, Kim SJ, Jo EH, Go GY, Choi HY, Im YS, Ha HY, Kim JH, Koo SK. Stem Cell Res. (IF 4.42) 2017 May;21:13-15.

  • Generation of hematopoietic stem cells from human embryonic stem cells using a defined, stepwise, serum-free, and serum replacement-free monolayer culture method. Kim SJ, Jung JW, Ha HY, Koo SK, Kim EG, Kim JH (교신저자). Blood Res. 2017 Mar;52(1):37-43.

  • Generation of a Nrf2 homozygous knockout human embryonic stem cell line using CRISPR/Cas9.Kim SJ, Habib O, Kim JS, Han HW, Koo SK, Kim JH (교신저자). Stem Cell Res. (IF 4.42). 2017 Mar;19:46-48.

  • A homozygous Keap1-knockout human embryonic stem cell line generated using CRISPR/Cas9 mediates gene targeting.Kim SJ, Habib O, Kim JS, Han HW, Koo SK, Kim JH (교신저자). Stem Cell Res. (IF 4.42) 2017 Mar;19:52-54.

  • 15-Deoxy-Δ12,14-prostaglandin J2 stabilizes hypoxia inducible factor-1α through induction of heme oxygenase-1 and direct modification ofprolyl-4-hydroxylase 2. Choi JE, Kim JH, Song NY, Suh J, Kim DH, Kim SJ, Na HK, Nadas J, Dong Z, Cha YN, Surh YJ.  Free Radic Res. (IF 2.89)   2016 Sep 

  • Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model. Sussan TE, Gajghate S, Thimmulappa RK, Ma J, Kim JH, Sudini K, Consolini N, Cormier SA, Lomnicki S, Hasan F, Pekosz A, Biswal S. PLoS One. (IF 2.74) 2015 Feb

  • Nrf2 is required for normal postnatal bone acquisition in mice. Kim JH (제1저자), Singhal V, Biswal S, Thimmulappa RK, DiGirolamo DJ. Bone Res. (IF 12.35, Cell & Tissue Engineering 상위 5%) 2014 Nov

  •  Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model. Sussan TE, Gajghate S, Thimmulappa RK, Ma J, Kim JH, Sudini K, Consolini N, Cormier SA, Lomnicki S, Hasan F, Pekosz A, Biswal S. PLoS One. (IF 2.74) 2015 Feb

  • Genetic silencing of Nrf2 enhances X-ROS in dysferlin-deficient muscle. Kombairaju P, Kerr JP, Roche JA, Pratt SJP, Lovering RM, Sussan TE, Kim JH, Shi G, Biswal S and Ward CW. Front Physiol. (IF 3.36) 2014 Feb

  • NRF2-mediated Notch pathway activation enhances hematopoietic reconstitution following myelosuppressive radiation. Kim JH (제1저자), Thimmulappa RK, Kumar V, Cui W, Kumar S, Kombairaju P, Zhang H, Margolick J, Matsui W, Macvittie T, Malhotra SV and Biswal S. J Clin Invest.  (IF 12.28) 2014 Feb

  • Oxidized phospholipids impair pulmonary antibacterial defenses: evidence in mice exposed to cigarette smoke. Thimmulappa RK, Gang X, Kim JH, Sussan TE, Witztum JL, Biswal S. Biochem Biophys Res Commun. (IF 2.99) 2012 Sep 21